Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis Outbreaks Growing Issue in Non-Hospital Settings
ATLANTA, Jan. 5 -- Outbreaks of viral hepatitis are a growing problem in non-hospital healthcare facilities, such as nursing homes and hemodialysis clinics, the CDC has warned. Over the past decade, there have been 33 outbreaks of hepatitis B and C in

FDA Approves Most Comprehensive System To Test Donated Blood For HIV, Hepatitis B & Hepatitis C
The United States Food & Drug Administration (FDA) approved a new nucleic acid test from Roche to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA in a single, automated assay. The test, called the cobas TaqScreen MPX Test

THATTA: Hepatitis on the rise in Thatta coastal areas
THATTA, Jan 4: As many as 362 new cases of hepatitis-C had been reported, most of them from remote coastal areas of the district, and various waterborne diseases were on the rise with over 90 per cent of water supply schemes not functioning, said

UPDATES AND COMMENTARY RSS Feed

Hepatitis C and Fibromyalgia: The Possible Link
Learn about the potential connection between Hepatitis C and fibromyalgia and find out why, due to similarities in manifestation and physiology, it is possible that Hepatitis C infection may act as one of fibromyalgia syndrome’s triggers. If you suspect having...

Hepatitis C Genotype Guides Health Plans
Because the suggested treatment length and success rates vary between genotypes, this is typically one of the first distinctions made after a Hepatitis C diagnosis. In order to assure the correct course of therapy is approved, health insurance companies are...

Math May Foretell Hepatitis C Drug Success
By doing a math formula calculation on the specific genetics of an individual's Hepatitis C infection, doctors may be able to predict whether or not treatment will be successful....

International Conference Reporter from

11th World Congress of Gastroenterology (WCOG)

Vienna, Austria

September 10, 1998

Liver biopsy in chronic hepatitis – why do it?

Dr P Scheuer, London, UK, provided strong arguments for the continued use of liver biopsy in diagnosis, pre- and post-treatment assessment, follow up, and research, in chronic hepatitis.

Biopsy adds much to liver function tests in diagnosis, and is essential for total assessment. Although HCV RNA in serum is now often used for diagnosis of Hepatitis C, biopsy can give more insight into the nature of disease, showing extent of inflammation and cirrhosis. Biopsy can also illustrate which disease is responsible for liver damage in cases of e.g. hepatitis plus thalassaemia.

In assessing patients’ need for treatment, biopsy is also useful. Originally, pathologists had difficulty in classifying hepatitis by histology alone, but a number of grading and staging systems have been used over the years. Clinicians require a numerical evaluation to assist their decisions to treat, and the simple algorithm of the METAVIR group has been very useful. This has a range of 0-3, and does not detect minor histological changes. On the other hand, the Knodell updated scoring allows a cumulative grading of 0-18, and a staging of 0-6. However, a ‘grading total’ figure should not be used to assume the need for therapy, since these numbers are not true measurements, but a hierarchy of gradings.

Although largely unnecessary for detecting cirrhosis nowadays, biopsy is still often used to do so. Pathology is also useful in identifying hepatocellular carcinoma when there is not obvious tumour mass, and negative serum alpha-fetoprotein.

Liver tissue is essential to cell-based research studies, such as analysis of cytotoxic lymphocytes in a diseased organ. Various in situ staining techniques obviously need tissue sections to be useful. As a concluding note, Dr Scheuer referred to a study which had shown that progression of fibrosis is related to age of the patient at infection, duration of disease, high alcohol intake, and male sex – purely derived by a sophisticated scoring system of biopsy pathology.

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2009 Hepatitis-Central.com
Updated 05 Jan 2009